| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 17 | |
| #2 | United States | 13 | |
| #3 | Australia | 8 | |
| #4 | EPO (European Patent Office) | 7 | |
| #5 | WIPO (World Intellectual Property Organization) | 6 | |
| #6 | Canada | 5 | |
| #7 | China | 5 | |
| #8 | Republic of Korea | 4 | |
| #9 | Mexico | 4 | |
| #10 | Singapore | 4 | |
| #11 | Israel | 3 | |
| #12 | New Zealand | 3 | |
| #13 | Brazil | 2 | |
| #14 | India | 1 | |
| #15 | Japan | 1 | |
| #16 | Russian Federation | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Medical technology | |
| #4 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Microorganisms | |
| #5 | Electrotherapy | |
| #6 | Climate change adaptation technologies | |
| #7 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Akle Charles | 46 |
| #2 | Grange John | 38 |
| #3 | Bilyard Kevin | 14 |
| #4 | Mudan Satvinder | 13 |
| #5 | Brunet Laura Rosa | 10 |
| #6 | Charles Akle | 5 |
| #7 | Kampinga Jakob | 4 |
| #8 | Burton Graham | 4 |
| #9 | Dalgleish Angus | 4 |
| #10 | Martyn Glen | 4 |
| Publication | Filing date | Title |
|---|---|---|
| GB202103578D0 | Prevention and treatment of infections including those caused by coronavirus | |
| GB202017752D0 | A mycobacterium for use in cancer therapy | |
| GB202017554D0 | Therapy | |
| GB202004007D0 | Coronavirus | |
| GB201919428D0 | Immunotherapeutic treatment of cancer | |
| EP3810193A1 | Cancer therapy | |
| GB201819943D0 | Immunotherapeutic treatment of cancer | |
| US2018185317A1 | Immunotherapeutic agent | |
| KR20180015269A | Checkpoint inhibitor for use in cancer treatment and whole cell of Mycobacterium | |
| GB201608806D0 | Method | |
| GB201601248D0 | Cancer therapy | |
| GB201511121D0 | Cancer therapy | |
| GB201511120D0 | Cancer therapy | |
| GB201322725D0 | Cancer therapy | |
| GB201308325D0 | Cancer Therapy | |
| GB201216800D0 | Novel use | |
| GB201120779D0 | Cancer therapy | |
| GB201118220D0 | Cancer therapy | |
| GB201020513D0 | Cancer therapy | |
| GB0921102D0 | Cancer Therapy |